|
|
|||||||||
Abbreviations: ALD: adrenoleukodystrophy AMN: adrenomyeloneuropathy CACT: carnitine acylcarnitine translocase CNS: central nervous system CPK: creatine phosphokinase CPS: carbamyl phosphate synthetase CPT: carnitine palmitoyltransferase CSF: cerebrospinal fluid GSD: glycogen storage disease LCAD: long-chain acyl-coA dehydrogenase LCFA: long-chain fatty acid MCAD: medium-chain acyl-coA dehydrogenase MLD: metachromatic leukodystrophy MPS: mucopolysaccharidosis mtDNA: mitochondrial DNA NAGS: N-acetyl glutamate synthetase nDNA: nuclear DNA OTC: ornithine transcarbamylase OXPHOS: oxidative phosphorylation RCDP: rhizomelic chondroplasia punctuate SCAD: short-chain acyl-coA dehydrogenase VLCAD: very long-chain acyl-coA dehydrogenase VLCFA: very long-chain fatty acids
| The first 300 words of the full text of this article appear below. |
The following article is included online only as a second part of the article "Inborn Errors of Metabolism: Part 1."
| Amino Acid Disorders |
|---|
Phenylketonuria, a disorder of phenylalanine metabolism, leads to intellectual disability if untreated.
Maple syrup urine disease involves an enzyme common to the degradation of the branched-chain amino acids (leucine, isoleucine, and valine). Although there are five subtypes of maple syrup urine disease, the classic form has a neonatal onset and generally progresses from poor feeding to coma and death if not treated.
Tyrosinemia also has multiple subtypes. Hepatorenal tyrosinemia (type I) may present with liver failure (elevated transaminase concentrations, hyperbilirubinemia, coagulopathy, ascites, and gastrointestinal bleeding) as well as kidney involvement (tubular dysfunction) and peripheral nerve involvement (painful crises, weakness or paralysis). Type II tyrosinemia is an oculocutaneous form of the disease that has corneal lesions and skin findings.
Homocystinuria, most commonly caused by cystathionine beta-synthase deficiency, presents with ocular (ectopia lentis), skeletal (marfanoid features such as dolichostenomelia and arachnodactyly), vascular (thromboembolic), and central nervous system (intellectual disability, stroke, and seizures) abnormalities.
When an amino acid disorder is suspected, measurement of plasma amino acids generally is sufficient to make the diagnosis. Assessment of urine amino acids can be helpful for homocystinuria and some abnormalities of amino acid transport (cystinuria, dicarboxylic amino aciduria) that affect the kidneys and for detecting generalized amino aciduria found with some kidney disease and mitochondrial disorders.
| Urea Cycle Disorders |
|---|
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | CME | ARCHIVE | SEARCH | TABLE OF CONTENTS |